Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02248454Completed
Open-label, single-arm trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Joslin Diabetes Center. Primary endpoint: Predictors of fat sensitivity. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02248454.